US Drug Recall Register

FDA Drug Recalls

2,277 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Norepinephrine Bitartrate in 5% Dextrose Injection

Reason Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

Baxter Healthcare Corporation D-0336-2024
Class II · Moderate risk Ongoing

Hydrogen Peroxide Oral Rinse

Reason CGMP Deviations: products may not conform to the labeled specifications.

Den-Mat Holdings, LLC NDC 59883-202-16 D-0287-2024
Class II · Moderate risk Ongoing

OralProCare medicated lip treatment

Reason CGMP Deviations: products may not conform to the labeled specifications.

Den-Mat Holdings, LLC NDC 59883-500-01 D-0286-2024
Class II · Moderate risk Ongoing

Vasostrict

Reason Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Par Sterile Products LLC D-0232-2024
Class II · Moderate risk Ongoing

Medline Remedy Clinical TREAT Antifungal Cream

Reason Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.

MEDLINE INDUSTRIES, LP - Northfield D-0315-2024
Class II · Moderate risk Ongoing

Ibuprofen and Famotidine Tablets 800mg/26.6mg

Reason Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.

Ascend Laboratories, LLC NDC 67877-626-90 D-0237-2024
Class II · Moderate risk Ongoing

Quality Choice No Drip Severe Congestion Nasal Pump Mist

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-608-01 D-0217-2024
Class II · Moderate risk Ongoing

Quality Choice No Drip Extra Moisturizing Nasal Pump Mist…

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-676-01 D-0216-2024
Class II · Moderate risk Ongoing

Premier Value Tussin Cough DM

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. D-0215-2024
Class II · Moderate risk Ongoing

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-607-01 D-0214-2024
Class II · Moderate risk Ongoing

Good Neighbor Pharmacy

Reason MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.

Pharma Nobis LLC NDC 46122-741-38 D-0227-2024
Class II · Moderate risk Ongoing

Selenium Sulfide 2.25% Shampoo

Reason CGMP Deviations: Stability data does not support expiry date.

Private Label Partners, Inc. NDC 42582-900-06 D-0152-2024
Class II · Moderate risk Ongoing

Sertraline Tablets

Reason CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Legacy Pharmaceutical Packaging LLC NDC 68645-523-54 D-0205-2024
Class II · Moderate risk Ongoing

Nystatin 150 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-1 D-0157-2024
Class II · Moderate risk Ongoing

Nystatin 2 Bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-4 D-0156-2024